Strategies for improving the efficacy of immunotherapy in hepatocellular carcinoma.

Zhu, Ying; Qin, Lun-Xiu

Zhu, Ying; Qin, Lun-Xiu.

Affiliation

Zhu Y; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Fudan University, Shanghai 200040, China; Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Qin LX; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Fudan University, Shanghai 200040, China; Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China. Electronic address: qinlx@fudan.edu.cn.

Hepatobiliary Pancreat Dis Int ; 21(5): 420-429, 2022 Oct.

Article in En | MEDLINE | ID: mdl-35977874

Subject(s)

Carcinoma, Hepatocellular; Liver Neoplasms; Antibodies, Monoclonal/therapeutic use; Carcinoma, Hepatocellular/drug therapy; Carcinoma, Hepatocellular/pathology; Humans; Immune Checkpoint Inhibitors/adverse effects; Immunologic Factors/therapeutic use; Immunotherapy/adverse effects; Liver Neoplasms/drug therapy; Liver Neoplasms/pathology; Nivolumab/therapeutic use; Protein Kinase Inhibitors/therapeutic use; Tumor Microenvironment

Key words

Hepatocellular carcinoma; Immune checkpoint inhibitors; Interferon-α; Programmed death receptor 1; Tumor microenvironment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Hepatobiliary Pancreat Dis Int Journal subject: GASTROENTEROLOGIA Year: 2022 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google